FIRST WAVE BIOPHARMA(NASDAQ:FWBI) stock News

FWBI Latest News, Press Relases and Analysis

All

Press Releases

a year ago - By: InvestorPlace

FWBI Stock Earnings: First Wave BioPharma Beats EPS for Q1 2024

a year ago - By: First Wave BioPharma, Inc.

First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market

a year ago - By: First Wave BioPharma, Inc.

First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month

a year ago - By: First Wave BioPharma, Inc.

First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients

2 years ago - By: First Wave BioPharma, Inc.

First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference

2 years ago - By: First Wave BioPharma, Inc.

First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference

2 years ago - By: InvestorPlace - Mentions: FSR SPRB DLTR

Why Is Fisker (FSR) Stock Down 41% Today?

2 years ago - By: InvestorPlace - Mentions: PRST

Why Is First Wave BioPharma (FWBI) Stock Up Today?

2 years ago - By: Benzinga - Mentions: PBM GERN SLS GRPH ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

2 years ago - By: Benzinga - Mentions: PATH APM CCTG LAC ...

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

2 years ago - By: InvestorPlace - Mentions: SPRB DLTR PRST

Why Is Spruce Biosciences (SPRB) Stock Down 78% Today?

2 years ago - By: InvestorPlace - Mentions: PRST HEAR CCTG PIXY ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

2 years ago - By: First Wave BioPharma, Inc.

First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline

2 years ago - By: First Wave BioPharma, Inc.

First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference

2 years ago - By: First Wave BioPharma, Inc.

First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024

2 years ago - By: First Wave BioPharma, Inc.

First Wave BioPharma to Present at the DealFlow MicroCap Conference

2 years ago - By: First Wave BioPharma, Inc.

First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico

2 years ago - By: Seeking Alpha

First Wave BioPharma files to sell 1.76M for holders (NASDAQ:FWBI)

2 years ago - By: Seeking Alpha

First Wave expecting "significant" investments if ImmunogenX deal closes (NASDAQ:FWBI)

2 years ago - By: First Wave BioPharma, Inc.

First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024

2 years ago - By: InvestorPlace - Mentions: DYN TPHS SASI CREV ...

FIRST WAVE BIOPHARMA (FWBI) Stock News

FWBI Latest News, Press Relases and Analysis

FWBI Stock Earnings: First Wave BioPharma Beats EPS for Q1 2024

First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market

First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month

First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients

First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference

First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference

Why Is Fisker (FSR) Stock Down 41% Today?

Why Is First Wave BioPharma (FWBI) Stock Up Today?

12 Health Care Stocks Moving In Friday's Pre-Market Session

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Why Is Spruce Biosciences (SPRB) Stock Down 78% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline

First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference

First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024

First Wave BioPharma to Present at the DealFlow MicroCap Conference

First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico

First Wave BioPharma files to sell 1.76M for holders (NASDAQ:FWBI)

First Wave expecting "significant" investments if ImmunogenX deal closes (NASDAQ:FWBI)

First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday